Women's sexual desire and arousal disorders

Journal of Sexual Medicine

Volumn 7, Issue 1 PART 2, 2010, Pages 586-614

  Brotto, Lori A ^a   Bitzer, Johannes ^b   Laan, Ellen ^c   Leiblum, Sandra ^d   Luria, Mijal ^e  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d Private Practice   (United States)

^e HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Assessment; Diagnosis; Female orgasmic disorder; Female sexual arousal disorder; Female sexual dysfunction; Hypoactive sexual desire disorder; Pathophysiology; Persistent genital arousal disorder; Treatment

Indexed keywords

AMFEBUTAMONE; ANESTHETIC AGENT; APOMORPHINE; BREMELANOTIDE; FLIBANSERIN; MOOD STABILIZER; PHENTOLAMINE; PLACEBO; PRASTERONE; PROSTAGLANDIN E1; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; TESTOSTERONE; TESTOSTERONE UNDECANOATE; TIBOLONE;

AGE; ANORGASMIA; ARTICLE; BREAST CANCER; CLINICAL TRIAL; COGNITIVE THERAPY; DIAGNOSTIC ACCURACY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; DISTRESS SYNDROME; DIZZINESS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; FATIGUE; HORMONAL THERAPY; HUMAN; HYPOACTIVE SEXUAL DESIRE DISORDER; INSOMNIA; INTERNATIONAL CLASSIFICATION OF DISEASES; INTERVIEW; LABORATORY TEST; LIBIDO DISORDER; MASTURBATION; MENOPAUSE; NAUSEA; NONHUMAN; ORGASM DISORDER; PELVIC FLOOR MUSCLE TRAINING; PERSISTENT GENITAL AROUSAL DISORDER; PHOTOELECTRIC PLETHYSMOGRAPHY; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; QUESTIONNAIRE; RISK FACTOR; SELF REPORT; SEX THERAPY; SEXUAL AROUSAL DISORDER; SEXUAL SATISFACTION; SOMNOLENCE; UNSPECIFIED SIDE EFFECT; VAGINA ATROPHY;

EID: 74049104720     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2009.01630.x     Document Type: Article

References (229)

1. Leiblum SR. Definition and classification of female sexual disorders. Int J Impot Res 1998, 10:S104-6.
2. Bozman AW, Beck JG. Covariation of sexual desire and sexual arousal: The effects of anger and anxiety. Arch Sex Behav 1991, 20:47-60.
3. Slob AK, Bax CM, Hop WCJ, Rowland DL, van der Werff ten Bosch JJ. Sexual arousability and the menstrual cycle. Psychoneuroendocrinology 1996, 2:545-58.
4. Sanders SA, Graham CA, Milhausen RR. Predicting sexual problems in women: The relevance of sexual excitation and sexual inhibition. Arch Sex Behav 2008, 37:241-51.
5. Brotto LA, Heiman JR, Tolman D. Narratives of desire in mid-age women with and without arousal difficulties. J Sex Res 2009, 46:387-98.
6. Graham CA, Sanders SA, Milhausen RR, McBride KR. Turning on and turning off: A focus group study of the factors that affect women's sexual arousal. Arch Sex Behav 2004, 33:527-38.
7. Hartmann U, Heiser K, Rüffer-Hesse C, Kloth G. Female sexual desire disorders: Subtypes, classification, personality factors and new directions for treatment. World J Urol 2002, 20:79-88.
8. Sand M, Fisher WA. Women's endorsement of models of female sexual response: The nurses' sexuality study. J Sex Med 2007, 4:708-19.
9. Brotto LA. The DSM diagnostic criteria for hypoactive sexual desire disorder. Arch Sex Behav DOI: 10.1007/S10508-009-9543-1
10. Diagnostic and statistical manual of mental disorders 2000, American Psychiatric Association, 4th, edition. Text Revision, Washington DC, American Psychiatric Association
11. Basson R, Leiblum S, Brotto L, Derogatis L, Fourcroy J, Fugl-Meyer K, Graziottin A, Heiman JR, Laan E, Meston C, Schover L, van Lankveld J, Weijmar Schultz W. Definitions of women's sexual dysfunction reconsidered: Advocating expansion and revision. J Psychosom Obstet Gynaecol 2003, 24:221-9.
12. Cain VS, Johannes CB, Avis NE, Mohr B, Schocken M, Skurnick J, Ory M. Sexual functioning and practices in a multi-ethnic study of midlife women: Baseline results from SWAN. J Sex Res 2003, 40:266-76.
13. Rosen RC, Shifren JL, Monz BU, Odom DM, Russo PA, Johannes CB. Correlates of sexually related personal distress in women with low sexual desire. J Sex Med 2009, 6:1549-60.
14. Dunn KM, Croft PR, Hackett GI. Satisfaction in the sex life of a general population sample. J Sex Marital Ther 2000, 26:141-51.
15. King M, Holt V, Nazareth I. Women's views of their sexual difficulties: Agreement and disagreement with clinical diagnoses. Arch Sex Behav 2007, 36:281-8.
16. Both S, Everaerd W, Laan E. Modulation of spinal reflexes by aversive and sexually appetitive stimuli. Psychophysiology 2003, 40:174-83.
17. Both S, Spiering M, Everaerd W, Laan E. Sexual behavior and responsiveness to sexual stimuli following laboratory-induced sexual arousal. J Sex Res 2004, 41:242-58.
18. Everaerd W, Laan E. Desire for passion: Energetics of sexual response. J Sex Marital Ther 1995, 21:255-63.
19. Laan E, Everaerd W. Determinants of female sexual arousal: Psychophysiological theory and data. Annu Rev Sex Res 1995, 6:32-76.
20. Laan E, Everaerd W, van der Velde J, Geer JH. Determinants of subjective experience of sexual arousal in women: Feedback from genital arousal and erotic stimulus content. Psychophysiology 1995, 32:444-51.
21. McCall K, Meston C. Differences between pre- and postmenopausal women in cues for sexual desire. J Sex Med 2007, 4:364-71.
22. Meston CM, Buss DM. Why humans have sex. Arch Sex Behav 2007, 36:477-507.
23. Basson R. Using a different model for female sexual response to address women's problematic low sexual desire. J Sex Marital Ther 2001, 27:395-403.
24. Basson R, Brotto LA, Balon R, Segraves RT. Management of low sexual desire in women. Clinical manual of sexual disorders 2009, 119-59. In, eds., Arlington, VI, American Psychiatric Publishing
25. Giles KR, McCabe MP. Conceptualising women's sexual function: Linear vs. circular models of sexual response. J Sex Med 2009, 6:2761-71.
26. Oberg K, Fugl-Meyer AR, Fugl-Meyer KS. On categorization and quantification of women's sexual dysfunctions: An epidemiological approach. Int J Impot Res 2004, 16:261-9.
27. Shifren JL, Monz BU, Russo PA, Segreti A, Johannes CB. Sexual problems and distress in United States women: Prevalence and correlates. Obstet Gynecol 2008, 112:970-8.
28. Bancroft J, Loftus J, Long JS. Distress about sex: A national survey of women in heterosexual relationships. Arch Sex Behav 2003, 32:193-208.
29. Nathan SG, Levine SB, Risen CB, Althof SE. When do we say a woman's sexuality is dysfunctional? Handbook of clinical sexuality for mental health professionals 2003, 95-110. In, eds., New York, Brunner-Routledge
30. Chivers M, Seto M, Lalumiere M, Laan E, Grimbos T. Agreement of genital and subjective measures of sexual arousal: A meta-analysis. Arch Sex Behav In Press
31. Laan E, Janssen E, Janssen E. How do men and women feel: Determinants of subjective experience of sexual arousal. The psychophysiology of sex 2007, 278-90. In, ed., Bloomington, IN, Indiana University Press
32. Heiman JR, Meston CM. Empirically validated treatment for sexual dysfunction. Ann Rev Sex Res 1997, 8:148-94.
33. Brotto LA, Basson R, Gorzalka BB. Psychophysiological assessment in premenopausal sexual arousal disorder. J Sex Med 2004, 1:266-77.
34. Graham CA. The DSM diagnostic criteria for female sexual arousal disorder. Arch Sex Behav 2009, Sep 24 [Epub ahead of print] doi:10.1007/S/0508-009-9535-1
35. Graham CA. The DSM diagnostic criterial for female orgasmic disorder. Arch Sex Behav 2009, Sep 26 [Epub ahead of print] doi: 10.1007/S10508-009-9542-2
36. Laumann EO, Paik A, Rosen R. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999, 281:537-44.
37. Fugl-Meyer AR, Sjogren Fugl-Meyer K. Sexual disabilities, problems and satisfaction in 18-74 years old Swedes. Scand J Sex 1999, 2:79-105.
38. Mercer CH, Fenton KA, Johnson AM, Wellings K, Macdowall W, McManus S, Nanchahal K, Erens B. Sexual function problems and help seeking behaviour in Britain: National probability sample survey. BMJ 2003, 327:426-7.
39. Laumann EO, Nicolosi A, Glasser DB, Paik A, Gingell C, Moreira E, Wang T. Sexual problems among women and men aged 40-80 years: Prevalence and correlates identified in the Global Study of Sexual Attitudes and Behaviors. Int J Impotence Res 2005, 17:39-57.
40. Leiblum SR, Koochaki PE, Rodenberg CA, Barton IP, Rosen RC. Hypoactive sexual desire disorder in postmenopausal women: US results from the Women's International Study of Health and Sexuality (WISHeS). Menopause 2006, 13:46-56.
41. Dennerstein L, Koochaki P, Barton I, Graziottin A. Hypoactive sexual desire disorder in menopausal women: A survey of western European women. J Sex Med 2006, 3:212-22.
42. West SL, D'Aloisio AA, Agans RP, Kalsbeek WD, Borisov NN, Thorp JM. Prevalence of low sexual desire and hypoactive sexual desire disorder in a nationally representative sample of US women. Arch Intern Med 2008, 168:1441-9.
43. Witting K, Santtila P, Varjonen M, Jern P, Johansson A, von der Pahlen B, Sandnabba K. Female sexual dysfunction, sexual distress, and compatibility with partner. J Sex Med 2008, 5:2587-99.
44. Hayes RD. Assessing female sexual dysfunction in epidemiological studies: Why is it necessary to measure both low sexual function and sexually-related distress? Sex Health 2008, 5:215-8.
45. Dunn KM, Croft PR, Hackett GI. Sexual problems: A study of the prevalence and need for health care in the general population. Fam Pract 1998, 15:519-24.
46. Basson R. Rethinking low sexual desire in women. Br J Obstet Gynaecol 2002, 109:357-63.
47. Basson R. Biopsychosocial models of women's sexual response: Applications to management of desire disorders. Sex Relat Ther 2003, 18:107-15.
48. Meston CM, Trapnell P. Development and validation of a five-factor sexual satisfaction and distress scale for women: The Sexual Satisfaction Scale for Women (SSS-W). J Sex Med 2005, 2:66-81.
49. Phillippsohn S, Hartmann U. Determinants of sexual satisfaction in a sample of German women. J Sex Med 2009, 6:1001-10.
50. Byers ES, Macneil S. Further validation of the interpersonal exchange model of sexual satisfaction. J Sex Marital Ther 2006, 32:53-69.
51. Lutfey K, Link C, Rosen R, Wiegel M, McKinlay J. Prevalence and correlates of sexual activity and function in women: Results from the Boston Area Community Health (BACH) survey. Arch Sex Behav 2009, 38:514-27.
52. Damasio A. Looking for Spinoza: Joy, sorrow, and the feeling brain 2003, Orlando, FL, Harcourt
53. Laan E, Both S. What makes women experience desire? Fem Psychol 2008, 18:505-14.
54. Dennerstein L, Alexander JL, Graziottin A, Porst H, Buvat J. Sexual desire disorder in women. Standard practice in sexual medicine 2006, 315-9. In, eds., Oxford, Blackwell Publishing
55. Bitzer J, Alder J. Sexuality during pregnancy and the postpartum period. J Sex Educ Ther 2000, 25:49-58.
56. Warnock JK, Clayton A, Croft H, Segraves R, Biggs FC. Comparison of androgens in women with hypoactive sexual desire disorder: Those on combined oral contraceptives (COCs) vs. those not on COCs. J Sex Med 2006, 3:878-82.
57. Bancroft J, Hammond G, Graham C. Do oral contraceptives produce irreversible effects on women's sexuality? J Sex Med 2006, 3:567.
58. Everaerd W, Both S, Laan E. The experience of sexual emotions. Ann Rev Sex Res 2006, 17:183-99.
59. Leonard LM, Follette VM. Sexual functioning in women reporting a history of child sexual abuse: Review of the empirical literature and clinical implications. Ann Rev Sex Res 2002, 13:346-88.
60. Fergusson DM, Mullen PE. Childhood sexual abuse: An evidence based perspective 1999, Thousand Oaks, CA, Sage
61. Meston CM, Heiman JR. Sexual abuse and sexual function: Examination of sexually relevant cognitive processes. J Consult Clin Psychol 2000, 68:399-406.
62. Oberg K, Fugl-Meyer K, Fugl-Meyer A. On sexual well-being in sexually abused Swedish women: Epidemiological aspects. Sex Relat Ther 2002, 17:329-41.
63. van Berlo W, Ensink B. Problems with sexuality after sexual assault. Ann Rev Sex Res 2000, 11:235-57.
64. Levin RJ, van Berlo W. Sexual arousal and orgasm in subjects who experience forced or non-consensual sexual stimulation-A review. J Clin Forensic Med 2004, 11:82-8.
65. Rellini AH, Meston CM. Sexual desire and linguistic analysis: A comparison of sexually-abused and non-abused women. Arch Sex Behav 2007, 36:67-77.
66. Elmerstig E, Wijma B, Swahnberg K. Young Swedish women's experience of pain and discomfort during sexual intercourse. Acta Obstet Gynecol Scand 2009, 88:98-103.
67. Cranston-Cuebas MA, Barlow DH. Cognitive and affective contributions to sexual functioning. Ann Rev Sex Res 1990, 1:119-61.
68. ter Kuile MM, Vigeveno D, Laan E. Preliminary evidence that acute and chronic daily psychological stress affect sexual arousal in sexually functional women. Behav Res Ther 2007, 45:2078-89.
69. Salemink E, van Lankveld JJ. The effects of increasing neutral distraction on sexual responding of women with and without sexual problems. Arch Sex Behav 2006, 35:175-86.
70. Adams AE, Haynes SN, Brayer MA. Cognitive distraction in female sexual arousal. Psychophysiology 1985, 22:689-96.
71. Dove NL, Wiederman MW. Cognitive distraction and women's sexual functioning. J Sex Marital Ther 2000, 26:67-78.
72. van Lankveld J, Bergh S. The interaction of state and trait aspects of self-focused attention affects genital, but not subjective, sexual arousal in sexually functional women. Behav Res Ther 2008, 46:514-28.
73. Barlow DH. Causes of sexual dysfunction: The role of anxiety and cognitive interference. J Consult Clin Psychol 1986, 54:140-8.
74. Norton GR, Jehu D. The role of anxiety in sexual dysfunctions: A review. Arch Sex Behav 1984, 13:165-83.
75. Cooper AJ. Some personality factors in frigidity. J Psychosom Res 1969, 13:149-55.
76. DeRogatis LR, Meyer JK. A psychological profile of the sexual dysfunction. Arch Sex Behav 1979, 8:201-23.
77. Kaplan HS. The sexual desire disorders 1995, New York, Brunner & Mazel
78. Campillo GG, Bravo CS, Carmona FM, Perales RD, Calderon AV. Anxiety and depression levels in women with and without sexual disorders: A comparative study. Rev Mex Psicol 1999, 16:17-23.
79. Trudel G, Landry L, Larose L. Low sexual desire: The role of anxiety, depression and marital adjustment. Sex Mar Ther 1997, 12:95-9.
80. Bartlik B, Kocsis JH, Legere R, Villaluz J, Kosoy A, Gelenberg AJ. Sexual dysfunction secondary to depressive disorders. J Gend Specif Med 1999, 2:52-60.
81. Apt C, Hurlbert DF. The sexual attitudes, behavior, and relationships of women with histrionic personality disorder. J Sex Marital Ther 1994, 20:125-33.
82. Wiederman MW. Women's body image self-consciousness during physical intimacy with a partner. J Sex Res 2000, 37:60-8.
83. Dean J, Rubio-Aurioles E, McCabe M, Eardley I, Speakman M, Buvat J, Tejada ISD, Fisher W. Integrating partners into erectile dysfunction treatment: Improving the sexual experience for the couple. Int J Clin Pract 2008, 62:127-33.
84. Rubio-Aurioles E, Kim ED, Rosen RC, Porst H, Burns P, Zeigler H, Wong DG. Impact on erectile function and sexual quality of life of couples: A double-blind, randomized, placebo-controlled trial of tadalafil taken once daily. J Sex Med 2009, 6:1314-23.
85. Klusmann D. Sexual motivation and the duration of partnership. Arch Sex Behav 2002, 31:275-87.
86. Laan E, van Driel EM, van Lunsen RHW. Genital responsiveness in healthy women with and without sexual arousal disorder. J Sex Med 2008, 5:1424-35.
87. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Fergson D, D'Agrostino R. The Female Sexual Function Index (FSFI): A multi-dimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000, 26:191-208.
88. Graziottin A, Leiblum S. Biological and psychosocial pathophysiology of female sexual dysfunction during the menopause transition. J Sex Med 2005, 2(3):S133-45. suppl
89. Rust J, Golombok S. The GRISS: A psychometric instrument for the assessment of sexual dysfunction. Arch Sex Behav 1986, 15:157-65.
90. Taylor JF, Rosen RC, Leiblum SR. Self-report assessment of female sexual function: Psychometric evaluation of the brief index of sexual functioning for women. Arch Sex Behav 1994, 23:627-43.
91. Spector IP, Carey MP, Steinberg L. The sexual desire inventory: Development, factor structure, and evidence of reliability. J Sex Marital Ther 1996, 22:175-90.
92. Derogatis LR. The Derogatis Interview for Sexual Functioning (DISF/DISF-SR): An introductory report. J Sex Marital Ther 1997, 23:291-304.
93. Meyer-Bahlburg HFL, Dolezal C. The Female Sexual Function Index: A methodological critique and suggestions for improvement. J Sex Marital Ther 2007, 33:217-24.
94. Brotto LA. Letter to the editor. J Sex Marital Ther 2009, 35:161-3.
95. Quirk FH, Heiman JR, Rosen RC, Laan E, Smith MD, Boolell M. Development of a sexual function questionnaire for clinical trials of female sexual dysfunction. J Womens Health Gend Based Med 2004, 11:277-89.
96. DeRogatis LR, Rosen R, Leiblum S, Burnett A, Heiman J. The Female Sexual Distress Scale (FSDS): Initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther 2002, 28:317-30.
97. Clayton AH, Segraves RT, Leiblum S, Basson R, Pyke R, Cotton D, Lewis-D'Agostino D, Evans KR, Sills TL, Wunderlich GR. Reliability and validity of the Sexual Interest and Desire Inventory-Female (SIDI-F), a scale designed to measure severity of female hypoactive sexual desire disorder. J Sex Marital Ther 2006, 32:115-35.
98. Leiblum S, Symonds T, Moore J, Soni P, Steinberg S, Sisson M. A methodology study to develop and validate a screener for hypoactive sexual desire disorder in postmenopausal women. J Sex Med 2006, 3:455-64.
99. DeRogatis L, Clayton A, Lewis-D'Agostino D, Wunderlich G, Fu Y. Validation of the female sexual distress scale-revised for assessing distress in women with hypoactive sexual desire disorder. J Sex Med 2008, 5:357-64.
100. Clayton AH, Goldfischer ER, Goldstein I, DeRogatis L, Lewis-D'Agostino DJ, Pyke R. Validation of the Decreased Sexual Desire Screener (DSDS): A brief diagnostic instrument for generalized acquired female hypoactive sexual desire disorder (HSDD). J Sex Med 2009, 6:730-8.
101. DeRogatis LR, Allgood A, Rosen RC, Leiblum S, Zipfel L, Guo C. Development and evaluation of the Women's Sexual Interest Diagnostic Interview (WSID): A structured interview to diagnose hypoactive sexual desire disorder (HSDD) in standardized patients. J Sex Med 2008, 5:2827-41.
102. Althof SE, Dean J, Derogatis LR, Rosen RC, Sisson M. Current perspectives on the clinical assessment and diagnosis of female sexual dysfunction and clinical studies of potential therapies: A statement of concern. J Sex Med 2005, 2:147-54.
103. Sintchak G, Geer JH. A vaginal plethysmograph system. Psychophysiology 1975, 12:113-5.
104. Levin RJ. The mechanisms of human female sexual arousal. Ann Rev Sex Res 1992, 3:1-48.
105. Wouda JC, Hartman PM, Bakker RM, Bakker JO, van de Wiel HBB, Weijmar Schultz WCM. Vaginal plethysmography in women with dyspareunia. J Sex Res 1998, 35:141-7.
106. Brauer M, Laan E, ter Kuile M. Sexual arousal in women with superficial dyspareunia. Arch Sex Behav 2006, 35:187-96.
107. Brauer M, ter Kuile MM, Janssen SA, Laan E. The effect of pain-related fear on sexual arousal in women with superficial dyspareunia. Eur J Pain 2007, 11:788-98.
108. Brauer M, ter Kuile MM, Laan E, Trimbos B. Cognitive-affective correlates and predictors of superficial dyspareunia. J Sex Marital Ther 2009, 35:1-24.
109. Meston CM, Gorzalka BB. Differential effects of sympathetic activation on sexual arousal in sexually dysfunctional and functional women. J Abnorm Psychol 1996, 105:582-91.
110. Morokoff PJ, Heiman JR. Effects of erotic stimuli on sexually functional and dysfunctional women: Multiple measures before and after sex therapy. Behav Res Ther 1980, 18:127-37.
111. Rellini A, Meston C. The sensitivity of event logs, self-administered questionnaires and photoplethysmography to detect treatment-induced changes in female sexual arousal disorder (FSAD) diagnosis. J Sex Med 2006, 3:283-91.
112. Wagner G, Levin R. Oxygen tension of the vaginal surface during sexual stimulation in the human. Fertil Steril 1978, 30:50-3.
113. Wagner G, Levin RJ. Effect of atropine and methylatropine on human vaginal blood flow, sexual arousal and climax. Acta Pharmacol Toxicol 1980, 46:321-5.
114. Wagner G, Ottesen B. Vaginal blood flow during sexual stimulation. Obstet Gynecol 1980, 56:621-4.
115. Hoon PW, Coleman E, Amberson J, Ling F. A possible physiological marker of female sexual dysfunction. Biol Psychiatry 1981, 16:1101-5.
116. Levin RJ, Wagner G. Sexual arousal in women: Which haemodynamic measure gives the best assessment? J Physiol 1980, 392:22-3P.
117. Slob AK, Ernste M, van der Werff ten Bosch JJ. Menstrual cycle phase and sexual arousability in women. Arch Sex Behav 1991, 20:567-77.
118. Slob AK, Koster J, Radder JK, van der Werff ten Bosch JJ. Sexuality and psychophysiological functioning in women with diabetes mellitus. J Sex Marital Ther 1990, 16:59-69.
119. Payne K, Binik Y. Reviving the labial thermistor clip. Arch Sex Behav 2006, 35:111-3.
120. Prause N, Heiman JR. Assessing female sexual arousal with the labial thermistor: Response specificity and construct validity. Int J Psychophysiol 2009, 72:115-22.
121. Henson DE, Rubin HB, Henson C. Labial and vaginal blood volume responses to visual and tactile stimuli. Arch Sex Behav 1982, 11:23-31.
122. Prause N, Janssen E, Goldstein I, Meston CM, Davis SR, Traish AM. Blood flow: Vaginal photoplethysmography. Women's sexual function and dysfunction: Study, diagnosis and treatment 2006, 359-67. In, eds., London, Taylor & Francis
123. Wagner G, Levin RJ, Gemme R, Wheeler CC. Human vaginal fluid, pH, urea, potassium and potential difference during sexual excitement. Profess in sexology: Selected proceedings of the 1976 international congress of sexology 1976, 335-44. In, eds., New York, Plenum Press
124. Lavoisier P, Aloui R, Schmidt MH, Watrelot A. Clitoral blood flow increases following vaginal pressure stimulation. Arch Sex Behav 1995, 24:37-45.
125. Kukkonen TM, Paterson L, Binik YM, Amsel R, Bouvier F, Khalifé S. Convergent and discriminant validity of clitoral color Doppler ultrasonography as a measure of female sexual arousal. J Sex Marital Ther 2006, 32:281-7.
126. Maravilla KR, Goldstein I, Meston CM, Davis SR, Traish AM. Blood flow: Magnetic resonance imaging and brain imaging for evaluating sexual arousal in women. Women's sexual function and dysfunction: Study, diagnosis and treatment 2006, 368-82. In, eds., London, Taylor & Francis
127. Kukkonen TM, Binik YM, Amsel R, Carrier S. Thermography as a physiological measure of sexual arousal in both men and women. J Sex Med 2007, 4:93-105.
128. Kukkonen TM, Binik YM, Amsel R, Carrier S. An evaluation of the validity of thermography as a physiological measure of sexual arousal in a non-university adult sample. Arch Sex Behav 2009, DOI: 10.1007/s10508-009-9496-4
129. Suh DD, Yang CC, Cao Y, Heiman JR, Garland PA, Maravilla KR. MRI of female genital and pelvic organs during sexual arousal. J Psychosom Obstet Gynaecol 2004, 25:153-62.
130. Maravilla KR, Cao Y, Heiman JR, Yang C, Garland PA, Peterson BT, Carter WO. Noncontrast dynamic magnetic resonance imaging for quantitative assessment of female sexual arousal. J Urol 2005, 173:162-6.
131. Maravilla KR, Heiman JR, Garland PA, Yunyu C, Carter WO, Peterson BT, Weisskoff RM. Dynamic MR imaging of the sexual arousal response in women. J Sex Marital Ther 2003, 29:71-6.
132. Maravilla KR, Cao Y, Heiman JR, Garland PA, Peterson BT, Carter WO, Weisskoff RM. Serial MR imaging with MS-325 for evaluating female sexual arousal response: Determination of intrasubject reproducibility. J Magn Reson Imaging 2003, 18:216-24.
133. Deliganis AV, Maravilla KR, Heiman JR, Carter WO, Garland PA, Peterson BT, Hackbert L, Cao Y, Weisskoff RM. Female genitalia: Dynamic MR imaging with use of MS-325-initial experiences evaluating female sexual response. Radiology 2002, 225:791-9.
134. Buisson O, Foldes P, Paniel B. Sonography of the clitoris. J Sex Med 2008, 5:413-7.
135. Foldes P, Buisson O. The clitoral complex: A dynamic sonographic study. J Sex Med 2009, 6:1223-31.
136. O'Connell HE, Hutson JM, Anderson CR, Plenter RJ. Anatomical relationship between urethra and clitoris. J Urol 1998, 159:1892-7.
137. Foldes P, Buisson O. Clitoris et point G: Liaison fatale. Gynécol Obstét Fertil 2007, 35:3-5.
138. Basson R. Sexual desire and arousal disorders in women. N Engl J Med 2006, 354:1497-506.
139. Cawood EH, Bancroft J. Steroid hormones, the menopause, sexuality and well-being of women. Psychol Med 1996, 26:925-36.
140. Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA 2005, 294:91-6.
141. Dennerstein L, Lehert P, Burger H. The relative effects of hormones and relationship factors on sexual function of women through the natural menopausal transition. Fertil Steril 2005, 84:174-80.
142. Dennerstein L, Randolph J, Taffe J, Dudley E, Burger H. Hormones, mood, sexuality, and the menopausal transition. Fertil Steril 2002, 77:42-8.
143. Gracia CR, Sammel MD, Freeman EW, Liu L, Hollander L, Nelson DB. Predictors of decreased libido in women during the late reproductive years. Menopause 2004, 11:144-50.
144. Gracia CR, Freeman EW, Sammel MD, Lin H, Mogul M. Hormones and sexuality during transition to menopause. Obstet Gynecol 2007, 109:831-40.
145. Santoro N, Torrens J, Crawford S, Allsworth JE, Finkelstein JS, Gold EB, Korenman S, Lasley WL, Luborsky JL, McConnell D, Sowers MF, Weiss G. Correlates of circulating androgens in mid-life women: The study of women's health across the nation. J Clin Endocrinol Metab 2005, 90:4836-45.
146. Gruber CJ, Tschugguel W, Schneeberger C, Huber JC. Production and actions of estrogens. N Engl J Med 2002, 346:340-52.
147. Semmens JP, Wagner G. Estrogen deprivation and vaginal function in postmenopausal women. JAMA 1982, 248:445-8.
148. Sarrel PM. Sexuality and menopause. Obstet Gynecol 1990, 75:S26-30.
149. Dennerstein L, Dudley EC, Hopper JL, Burger H. Sexuality, hormones and the menopausal transition. Maturitas 1997, 26:83-93.
150. Guthrie JR, Dennerstein L, Taffe JR, Lehbert P, Burger HG. The menopausal transition: A 9 years prospective population-based study. The Melbourne women's midlife health project. Climacteric 2004, 7:375-89.
151. Dennerstein L, Dudley E, Burger H. Are changes in sexual functioning during midlife due to aging or menopause? Fertil Steril 2001, 76:456-60.
152. Freeman EW, Sammel MD, Lin H, Gracia CR, Pien GW, Nelson DB, Sheng L. Symptoms associated with menopausal transition and reproductive hormones in midlife women. Obstet Gynecol 2007, 110:230-40.
153. Tungphaisal S, Chandeying V, Sutthijumroon S, Krisanapan O, Udomratn P. Postmenopausal sexuality in Thai women*. Asia Oceania J Obstet Gynaecol 1991, 17:143-6.
154. Avis ME, Stellato R, Crawford SL, Johannes CB, Longcope C. Is there an association between menopause status and sexual functioning? Menopause 2000, 7:297-309.
155. Modelska K, Litwack S, Ewing SK, Yaffe K. Endogenous estrogen levels affect sexual function in elderly post-menopausal women. Maturitas 2004, 49:124-33.
156. Gerber JR, Johnson JV, Bunn JY, O'Brien SL. A longitudinal study of the effects of free testosterone and other psychosocial variables on sexual function during the natural traverse of menopause. Fertil Steril 2005, 83:643-8.
157. Komisaruk BR, Adler NT, Hutchison J. Genital sensory field: Enlargement by estrogen treatment in female rats. Science 1972, 178:1295-8.
158. Foster DC, Palmer M, Marks J. Effect of vulvovaginal estrogen on sensorimotor response of the lower genital tract: A randomized controlled trial. Obstet Gynecol 1999, 94:232-7.
159. Romanzi LJ, Groutz A, Feroz F, Blaivas JG. Evaluation of female external genitalia sensitivity to pressure/touch: A preliminary prospective study using Semmes-Weinstein monofilaments. Urology 2001, 57:1145-50.
160. Longcope C. Adrenal and gonadal androgen secretion in normal females. J Clin Endocrinol Metab 1986, 15:213-28.
161. Bachmann G, Bancroft J, Braunstein G, Burger H, Davis S, Dennerstein L, Goldstein I, Guay AL, Leiblum S, Lobo R, Notelovitz M, Rosen R, Sarrel P, Sherwin B, Simon J, Simpson ES, Shifren J, Spark R, Traish A. Female androgen insufficiency: The Princeton consensus statement on definition, classification, and assessment. Fertil Steril 2002, 77:660-5.
162. Labrie F, Luu-The V, Lin S, Simard J, Labrie C. Role of 17β-hydroxysteroid dehydrogenases in sex steroid formation in peripheral intracrine tissues. Trends Endocrinol Metab 2000, 11:421-7.
163. Luu-The V, Dufort I, Pelletier G, Labrie F. Type 5 17β-hydroxysteroid dehydrogenase: Its role in the formation of androgens in women. Mol Cell Endocrinol 2001, 171:77-82.
164. Labrie F, Belanger A, Cusan L, Gomez J, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997, 82:2396-402.
165. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: Changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005, 90:3847-53.
166. Wierman ME, Basson R, Davis SR, Khosla S, Miller KK, Rosner W, Santoro N. Androgen therapy in women: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006, 91:3697-716.
167. Traish A, Guay AT, Spark RF. Testosterone therapy in women study group. Are the Endocrine Society's Clinical Practice Guidelines on androgen therapy in women misguided? A commentary. J Sex Med 2007, 4:1223-35.
168. Wang C, Catlin DH, Demers LM, Starcevic B, Swerdloff RS. Measurement of total serum testosterone in adult men: Comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. J Clin Endocrinol Metab 2004, 89:534-43.
169. Demers LM. Testosterone and estradiol assays: Current and future trends. Steroids 2008, 73:1333-8.
170. King SR. Emerging roles for neurosteroids in sexual behavior and function. J Androl 2008, 29:524-33.
171. Graham CA, Bancroft J, Doll HA, Greco T, Tanner A. Does oral contraceptive-induced reduction in free testosterone adversely affect the sexuality or mood of women? Psychoneuroendocrinology 2007, 32:246-55.
172. Steiner M, Dunn E, Born L. Hormones and mood: From menarche to menopause and beyond. J Affect Disord 2003, 74:67-83.
173. Freeman EW, Sammel MD, Lin H, Nelson DB. Associations of hormones and menopausal status with depressed mood in women with no history of depression. Arch Gen Psychiatry 2006, 63:375-82.
174. Kruger TH, Hartmann U, Schedlowski M. Prolactinergic and dopaminergic mechanisms underlying sexual arousal and orgasm in humans. World J Urol 2005, 23:130-8.
175. Mishra G, Kuh D. Sexual functioning throughout menopause: The perceptions of women in a British cohort. Menopause 2006, 13:880-90.
176. Aziz A, Brännström M, Bergquist C, Silfverstolpe G. Perimenopausal androgen decline after oophorectomy does not influence sexuality or psychological well-being. Fertil Steril 2005, 83:1021-8.
177. Teplin V, Vittinghoff E, Lin F, Learman LA, Richter HE, Kuppermann M. Oophorectomy in premenopausal women: Health-related quality of life and sexual functioning. Obstet Gynecol 2007, 109:347-54.
178. Farquhar CM, Harvey SA, Yu Y, Sadler L, Stewart AW. A prospective study of 3 years of outcomes after hysterectomy with and without oophorectomy. Am J Obstet Gynecol 2006, 194:711-7.
179. Graham CA, Bancroft J, Andreasen N, Gelder M, Lopez-Ibor J, Geddes J. The sexual dysfunctions. New oxford textbook of psychiatry 472-83. In, eds., 2nd, edition, Oxford, Oxford University Press, in press
180. Balon R. The DSM criteria of sexual dysfunction: Need for a change. J Sex Marital Ther 2008, 34:186-97.
181. Balon R, Segraves RT, Clayton A. Issues for DSM-V: Sexual dysfunction, disorder, or variation along normal distribution: Toward rethinking DSM criteria of sexual dysfunctions. Am J Psychiatry 2007, 164:198-200.
182. Trudel G, Marchand A, Ravart M, Aubin S, Turgeon L, Fortier P. The effect of a cognitive behavioral treatment program on hypoactive sexual desire in women. Sex Relat Ther 2001, 16:145-64.
183. Hawton K, Catalan J, Fagg J. Low sexual desire: Sex therapy results and prognostic factors. Behav Res Ther 1991, 29:217-24.
184. Sarwer DB, Durlak JA. A field trial of the effectiveness of behavioral treatment for sexual dysfunctions. J Sex Marital Ther 1997, 23:87-97.
185. Brotto LA, Basson R, Luria M. A mindfulness-based group psychoeducational intervention targeting sexual arousal disorder in women. J Sex Med 2008, 5:1646-59.
186. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen R, Leiblum SR, Caramelli KE, Mazer NA. Transdermal testosterone treatment in women with impaired sexual function after oopherectomy. N Engl J Med 2000, 343:682-8.
187. Braunstein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA, Bachmann G, Aguirre OA, Lucas JD, Rodenberg C, Buch A, Watts NB. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: A randomized, placebo-controlled trial. Arch Intern Med 2005, 165:1582-9.
188. Lobo RA, Belisle S, Creasman WT, Frankel NR, Goodman NF, Hall JE, Ivey SL, Kingsberg S, Langer R, Lehman R, McArthur DB, Montgomery-Rice V, Notelovitz M, Packin GS, Rebar RW, Rousseau M, Schenken RS, Schneider DL, Sherif K, Wysocki S. Should symptomatic menopausal women be offered hormone therapy? MedGenMed 2006, 8:40.
189. Shifren JL, Davis SR, Moreau M, Waldbaum A, Bouchard C, DeRogatis L, Derzko C, Bearnson P, Kakos N, O'Neill S, Levine S, Wekselman K, Buch A, Rodenberg C, Kroll R. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: Results from the INTIMATE NM1 Study. Menopause 2006, 13:770-9.
190. Kingsberg S. Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women. J Sex Med 2007, 4:227-34.
191. Davis SR, Moreau M, Kroll R, Bouchard C, Panay N, Gass M, Braunstein GD, Hirschberg AL, Rodenberg C, Pack S, Koch H, Moufarege A, Studd J. Testosterone for low libido in postmenopausal women not taking estrogen. N Engl J Med 2008, 359:2005-17.
192. Nijland EA, Schultz WCMW, Nathorst-Boös J, Helmond FA, Van Lunsen RH, Palacios S, Norman RJ, Mulder RJ, Davis SR. Tibolone and transdermal E2/NETA for the treatment of female sexual dysfunction in naturally menopausal women: Results of a randomized active-controlled trial. J Sex Med 2008, 5:646-56.
193. Laan E, van Lunsen RHW, Everaerd W. The effects of tibolone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric 2001, 4:28-41.
194. Segraves RT, Clayton A, Croft H, Wolf A, Warnock J. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol 2004, 24:339-42.
195. Clayton AH, Warnock JK, Kornstein SG, Pinterton R, Sheldon-Keller A, McGarvey EL. A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 2004, 65:62-7.
196. http://www.boehringer-ingelheim.com/corporate/news/press_releases/detail.asp?ID=7095, Boehringer-Ingelheim news release, Available at: (retrieved November 16, 2009
197. Both S, Laan E, O'Donohue W, Fisher JE, Hayes SC. Directed masturbation. Cognitive behavior therapy: Applying empirically supported techniques in your practice 2003, 144-51. In, eds., New York, John Wiley & Sons
198. Tuiten A, Laan E, Panhuysen G, Everaerd W, de Haan E, Koppeschaar H, Vroon P. Discrepancies between genital responses and subjective sexual function during testosterone substitution in women with hypothalamic amenorrhea. Psychosom Med 1996, 58:234-41.
199. The role of local vaginal estrogen for treatment of vaginal atrophy: 2007 position statement of the North American Menopause Society. NAMS 2007, 14:355-6. The North American Menopause Society
200. Suckling J, Lethaby A, Kennedy R. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev 2006, 4:CD001500.
201. Uygur D, Yeşildaglar N, Erkaya S. Effect on sexual life-A comparison between tibolone and continuous combined conjugated equine estrogens and medroxyprogesterone acetate. Gynecol Endocrinol 2005, 20:209-12.
202. Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez J, Girard G, Baron M, Normand A, Moreau M, Dube R, Cote I, Labrie C, Lavoie L, Berger L, Gilbert L, Martel C, Baker J. Intravaginal dehydroepiandrosterone (Prasterone), a physiological and a highly efficient treatment of vaginal atrophy. Menopause 2009, 16:907-22.
203. Labrie F, Archer D, Bouchard C, Fortier M, Cusan L, Gomez J, Girard G, Baron M, Ayotte N, Moreau M, Dube R, Cote I, Labrie C, Lavoie L, Berube R, Belanger P, Berger L, Gilbert L, Martel C, Balser J. Effect of intravaginal dehydroepiandrosterone (Prasterone) on libido and sexual dysfunction in postmenopausal women. Menopause 2009, 16:923-31.
204. Laan E, van Lunsen RHW, Everaerd W, Riley A, Scott E, Boolell M. The enhancement of vaginal vasocongestion by sildenafil in healthy premenopausal women. J Womens Health Gend Based Med 2002, 11:357-65.
205. Basson R, McInnes R, Smith MD, Hodgson G, Koppiker N. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med 2002, 11:339-49.
206. Berman JR, Berman LA, Toler SM, Gill J, Haughies S. Safety and efficacy of sildenafil citrate for the treatment of female sexual arousal disorder: A double-blind, placebo controlled study. J Urology 2003, 170:2333-8.
207. Caruso S, Intelisano G, Lupo L, Agnello C. Premenopausal women affected by sexual arousal disorder treated with sildenafil: A double-blind, cross-over, placebo-controlled study. Br J Obstet Gynaecol 2001, 108:623-8.
208. Basson R, Brotto LA. Sexual psychophysiology and effects of sildenafil citrate in oestrogenised women with acquired genital arousal disorder and impaired orgasm: A randomised controlled trial. BJOG 2003, 110:1014-24.
209. Sipski M, Rosen R, Alexander CJ, Hamer RM. Sildenafil effects on sexual and cardiovascular responses in women with spinal cord injury. Urology 2000, 55:812-5.
210. Caruso S, Rugolo S, Agnello C, Intelisano G, Di Mari L, Cianci A. Sildenafil improves sexual functioning in premenopausal women with type 1 diabetes who are affected by sexual arousal disorder: A double-blind, crossover, placebo-controlled pilot study. Fertil Steril 2006, 85:1496-501.
211. Islam A, Mitchel J, Rosen R, Phillips NA, Ayers C, Ferguson D, Yeager J. Topical alprostadil in the treatment of female sexual arousal disorder: A pilot study. J Sex Marital Ther 2001, 27:531-40.
212. Fourcroy JL. Female sexual dysfunction: Potential for pharmacotherapy. Drugs 2003, 63:1445-57.
213. Rosen R, Phillips NA, Gendrano NGI. Oral phentolamine and female sexual arousal disorder: A pilot study. J Sex Marital Ther 1999, 25:137-44.
214. Rubio-Aurioles E, Lopez M, Lipezker M, Lara C, Ramirez A, Rampazzo C, Hurtado de Mendoza MT, Lowrey F, Loehr LA, Lammers P. Phentolamine mesylate in postmenopausal women with female sexual arousal disorder: A psychophysiological study. J Sex Marital Ther 2002, 28:S205-15.
215. Both S, Everaerd W, Laan E, Gooren L. Effect of a single dose of levodopa on sexual response in men and women. Neuropsychopharmacology 2005, 30:173-83.
216. Caruso S, Agnello C, Intelisano G, Farina M, Di Mari L, Cianci A. Placebo-controlled study on efficacy and safety of daily apomorphine sl intake in premenopausal women affected by hypoactive sexual desire disorder and sexual arousal disorder. Urology 2004, 63:955-9.
217. Diamond LE, Earle DC, Heiman JR, Rosen RC, Perelman MA, Harning R. An effect on the subjective sexual response in premenopausal women with sexual arousal disorder by bremelanotide (PT-141), a melanocortin receptor agonist. J Sex Med 2006, 3:628-38.
218. Meston C, Hull EM, Levin RJ, Sipski M, Lue TF, Basson R, Rosenet R, Giuliano F, Khoury S, Montorsi F. Women's orgasm. Sexual medicine: Sexual dysfunctions in men and women 2004, 783-850. In, eds., Paris, Health Publications
219. Dunn KM, Cherkas LF, Spector TD. Genetic influences on variation in female orgasmic function: a twin study. Biol Lett 2005, 1:260-3.
220. Nurnberg HG, Hensley PL, Heiman JR, Croft HA, Debattista C, Paine S. Sildenafil treatment of women with antidepressant-associated sexual dysfunction: A randomized controlled trial. JAMA 2008, 300:395-404.
221. Buckler HM, Robertson WR, Wu FC. Which androgen replacement therapy for women? J Clin Endocrinol Metab 1998, 83:3920-4.
222. Davis S, Papalia M, Norman RJ, O'Neill S, Redelman M, Williamson M, Stuckey BGA, Wlodarczyk J, Gard'ner K, Humberstone A. Safety and efficacy of a testosterone metered-dose transdermal spray for treating decreased sexual satisfaction in premenopausal women: A randomized trial. Ann Intern Med 2008, 148:569-77.
223. Bradford A, Meston CM. Placebo response in the treatment of women's sexual dysfunctions: A review and commentary. J Sex Marital Ther 2009, 35:164-81.
224. Bradford A, Meston C. Correlates of placebo response in the treatment of sexual dysfunction in women: A preliminary report. J Sex Med 2007, 4:1345-51.
225. Leiblum S, Brown C, Wan J, Rawlinson L. Persistent sexual arousal syndrome: A descriptive study. J Sex Med 2005, 2:331-7.
226. Goldstein I, De EJB, Johnson J, Goldstein I, Meston C, Davis S, Traish A. Persistent sexual arousal syndrome and clitoral priapism. Women's sexual function and dysfunction: Study, diagnosis and treatment 2006, 674-85. In, eds., London, Taylor and Francis
227. Leiblum SR, Chivers ML. Normal and persistent genital arousal in women: New perspectives. J Sex Marital Ther 2007, 33:357-73.
228. Leiblum S. Persistent genital arousal disorder: What it is and what it isn't. Contemp Sex 2006, 40:8-13.
229. Leiblum S, Leiblum S. Persistent genital arousal disorder. Principles and practice of sex therapy 2005, 54-83. In, ed., New York, Guilford Press